Fat targets for skeletal health.

Document Type


Publication Date



Animals, Bone-Density, Bone-Remodeling, Bone-and-Bones, Disease-Models-Animal, Energy-Metabolism, Homeostasis, Humans, Leptin, Mice-Knockout, Osteocalcin, Osteoporosis, PPAR-gamma

First Page


Last Page


JAX Location

see Reprint Collection (a pdf is available)

JAX Source

Nat Rev Rheumatol 2009 Jul; 5(7):365-72.


Emerging evidence points to a critical role for the skeleton in several homeostatic processes, including energy balance. The connection between fuel utilization and skeletal remodeling begins in the bone marrow with lineage allocation of mesenchymal stem cells to adipocytes or osteoblasts. Mature bone cells secrete factors that influence insulin sensitivity, and fat cells synthesize cytokines that regulate osteoblast differentiation; thus, these two pathways are closely linked. The emerging importance of the bone-fat interaction suggests that novel molecules could be used as targets to enhance bone formation and possibly prevent fractures. In this article, we discuss three pathways that could be pharmacologically targeted for the ultimate goal of enhancing bone mass and reducing osteoporotic fracture risk: the leptin, peroxisome proliferator-activated receptor gamma and osteocalcin pathways. Not surprisingly, because of the complex interactions across homeostatic networks, other pathways will probably be activated by this targeting, which could prove to be beneficial or detrimental for the organism. Hence, a more complete picture of energy utilization and skeletal remodeling will be required to bring any potential agents into the future clinical armamentarium.

Please contact the Joan Staats Library for information regarding this document.